According to a recent study, female psoriasis patients have shorter drug survival for biologics compared to men.
Study shows unmet need with frequent flares in PsO patients
According to a recent study, patients with generalized pustular psoriasis experience frequent flares that are typically uncontrolled by off-label therapies.
Parallel-beam ultrasound effective for Asian facial acne scars
According to a recent study, a high-intensity, high-frequency, non-focused ultrasound parallel beams device was efficacious and safe in the treatment of facial acne scars in Asian patients.
Body roundness linked to increased risk of psoriasis
According to a recent study, an increased Body Roundness Index score, an indicator of abdominal obesity, is associated with an increased risk of psoriasis.
Study shows Ialuxid gel successful in treating mild-to-moderate acne
According to a recent study, a gel consisting of a combination of hyaluronic acid, hydrogen peroxide, and glycine is effective in treating mild-to-moderate acne vulgaris.
Concomitant application of insect repellent, sunscreen impairs UV protection
According to a recent study, applying both insect repellent and sunscreen may impair the efficacy of UV protection.
Tattoo ink may be linked to increased risk of lymphoma
According to a recent study, individuals with tattoos are more likely to be diagnosed with skin and lymphoma cancers than those without tattoos.
Study shows induction therapy with ixekizumab may lower drug survival
According to a recent study, induction therapy with ixekizumab in patients with moderate-to-severe plaque psoriasis may offer faster symptom relief but shows lower long-term drug survival.
Recent study suggests plant-rich diets with low saturated fats may be associated with reduced PsO severity
According to a recent study, healthier eating patterns may be linked to psoriasis severity.
Oral roflumilast efficacious in treating moderate-to-severe plaque PsO
According to a recent real-world study, oral roflumilast was efficacious in reducing disease severity in moderate-to-severe plaque psoriasis.
HealthMinute.TV 